Search results :

Skin disorder

Definition: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.

Synonyms (terms occurring on more labels are shown first): skin disorder, skin disorders, dermatoses, Dermatologic diseases, cutaneous disorders, skin conditions, dermatosis, disordersSkin, skin disease, dermatologic disorders, Disorders Skin, dermatological disorders, skin diseases, Dermatological Diseases, skin condit ions, disease Skin, Dermatologic Disease

More information: PubMed search and possibly Wikipedia

Show drugs for which this side effect directly occurs

Drugs with this side effect as MedDRA Preferred Term

  • 1,25(OH)2D3
    • Skin disorder
  • 4-AP
    • Unspecified disorder of skin and subcutaneous tissue
  • 4-PBA
    • Unspecified disorder of skin and subcutaneous tissue
  • 5-ASA
    • Unspecified disorder of skin and subcutaneous tissue
  • 5-aminolevulinic acid
    • Skin disorder: 0% - 12%
    • Unspecified disorder of skin and subcutaneous tissue
  • 5-aza-2'-deoxycytidine
    • Unspecified disorder of skin and subcutaneous tissue
  • 5-azacytidine
    • Unspecified disorder of skin and subcutaneous tissue
  • 6-mercaptopurine
    • Unspecified disorder of skin and subcutaneous tissue: 2%
  • 8-MOP
    • Skin disorder
  • A77 1726
    • Unspecified disorder of skin and subcutaneous tissue
  • ACTH(1-39
    • Unspecified disorder of skin and subcutaneous tissue
  • AMD3100
    • Unspecified disorder of skin and subcutaneous tissue
  • APAs
    • Unspecified disorder of skin and subcutaneous tissue
  • Anidulafungin
    • Unspecified disorder of skin and subcutaneous tissue: 22.9% - 25.6%
  • Azarga
    • Unspecified disorder of skin and subcutaneous tissue
  • Bivalirudin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • Buscopan
    • Unspecified disorder of skin and subcutaneous tissue
  • CGP 19835A
    • Unspecified disorder of skin and subcutaneous tissue
  • Cancidas
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 15% - 42%
  • D-penicillamine
    • Unspecified disorder of skin and subcutaneous tissue
  • DFMO
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • Diane-35
    • Unspecified disorder of skin and subcutaneous tissue
  • Enfuvirtide
    • Unspecified disorder of skin and subcutaneous tissue
  • Eptifibatide
    • Unspecified disorder of skin and subcutaneous tissue
  • Estrofem
    • Unspecified disorder of skin and subcutaneous tissue
  • FK463
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 14.3% - 79.2%
  • FTY720
    • Unspecified disorder of skin and subcutaneous tissue
  • Forteo
    • Unspecified disorder of skin and subcutaneous tissue
  • Gd-DTPA
    • Unspecified disorder of skin and subcutaneous tissue
  • Gd-EOB-DTPA
    • Unspecified disorder of skin and subcutaneous tissue
  • Glat copolymer
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • Goserelin
    • Unspecified disorder of skin and subcutaneous tissue
  • Histrelin
    • Unspecified disorder of skin and subcutaneous tissue
  • ICI 182,780
    • Unspecified disorder of skin and subcutaneous tissue
  • Implanon
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • Insulin
    • Unspecified disorder of skin and subcutaneous tissue
  • K779
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • LY146032
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, rare, 30% - 34.5%
  • Lantus
    • Unspecified disorder of skin and subcutaneous tissue
  • Leuprorelin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • Lisinopril
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • Lu AA21004
    • Unspecified disorder of skin and subcutaneous tissue
  • Lyxumia
    • Unspecified disorder of skin and subcutaneous tissue
  • MDV3100
    • Unspecified disorder of skin and subcutaneous tissue
  • Metrodin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
  • N-acetylcysteine
    • Unspecified disorder of skin and subcutaneous tissue
  • N-carbamylglutamate
    • Unspecified disorder of skin and subcutaneous tissue
  • NTBC
    • Unspecified disorder of skin and subcutaneous tissue
  • NovoLog
    • Skin disorder: 2% - 5%
    • Unspecified disorder of skin and subcutaneous tissue
  • NuvaRing
    • Unspecified disorder of skin and subcutaneous tissue
  • Nuvocid
    • Unspecified disorder of skin and subcutaneous tissue
  • Octreotide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
    • Skin disorder
  • Oestrogen
    • Unspecified disorder of skin and subcutaneous tissue
  • Optison
    • Unspecified disorder of skin and subcutaneous tissue
  • PCI-32765
    • Unspecified disorder of skin and subcutaneous tissue
  • PGE1
    • Skin disorder
  • Photofrin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: 1.45% - 52.5%
  • Photofrin II
    • Unspecified disorder of skin and subcutaneous tissue
  • Promacta
    • Unspecified disorder of skin and subcutaneous tissue
  • Refludan
    • Unspecified disorder of skin and subcutaneous tissue
  • Revasc
    • Unspecified disorder of skin and subcutaneous tissue
  • SU5416
    • Unspecified disorder of skin and subcutaneous tissue
  • Saxagliptin
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue
  • SonoVue
    • Unspecified disorder of skin and subcutaneous tissue
  • Supremon
    • Skin disorder: 1.79%
    • Unspecified disorder of skin and subcutaneous tissue
  • TMC435
    • Unspecified disorder of skin and subcutaneous tissue
  • TPGS
    • Unspecified disorder of skin and subcutaneous tissue
  • TR-700
    • Unspecified disorder of skin and subcutaneous tissue
  • Terlipressin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • Triphasil
    • Unspecified disorder of skin and subcutaneous tissue
  • Triptorelin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • Trisequens
    • Unspecified disorder of skin and subcutaneous tissue
  • UDCA
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • VACV
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • Vancocine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • abacavir
    • Unspecified disorder of skin and subcutaneous tissue
  • abacavir-lamivudine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • abiraterone
    • Unspecified disorder of skin and subcutaneous tissue
  • acamprosate
    • Unspecified disorder of skin and subcutaneous tissue: common
  • acebutolol
    • Unspecified disorder of skin and subcutaneous tissue: 1%
  • acetaminophen
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • acitretin
    • Skin disorder: postmarketing
  • acyclovir
    • Unspecified disorder of skin and subcutaneous tissue
  • adefovir dipivoxil
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • afatinib
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • agomelatine
    • Unspecified disorder of skin and subcutaneous tissue
  • albendazole
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • alfentanil
    • Unspecified disorder of skin and subcutaneous tissue
  • alfuzosin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • aliskiren
    • Unspecified disorder of skin and subcutaneous tissue
  • allopurinol
    • Unspecified disorder of skin and subcutaneous tissue
  • almotriptan
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • alosetron
    • Skin disorder
  • alprazolam
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, infrequent, 1.1%
  • amantadine
    • Unspecified disorder of skin and subcutaneous tissue
  • amiodarone
    • Skin disorder
  • amisulpride
    • Skin disorder: 0% - 1%
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • amlodipine
    • Unspecified disorder of skin and subcutaneous tissue
  • amlodipine besylate
    • Unspecified disorder of skin and subcutaneous tissue
  • amoxicillin
    • Unspecified disorder of skin and subcutaneous tissue
  • amphetamine
    • Unspecified disorder of skin and subcutaneous tissue
  • amphotericin B
    • Skin disorder
  • amprenavir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • amsacrine
    • Unspecified disorder of skin and subcutaneous tissue
  • anagrelide
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • apixaban
    • Unspecified disorder of skin and subcutaneous tissue
  • apraclonidine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • apremilast
    • Unspecified disorder of skin and subcutaneous tissue
  • aprepitant
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • aripiprazole
    • Unspecified disorder of skin and subcutaneous tissue
  • arsenic trioxide
    • Unspecified disorder of skin and subcutaneous tissue
  • articaine
    • Skin disorder
  • atazanavir
    • Unspecified disorder of skin and subcutaneous tissue
  • atomoxetine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • atorvastatin
    • Unspecified disorder of skin and subcutaneous tissue
  • atosiban
    • Unspecified disorder of skin and subcutaneous tissue
  • atovaquone
    • Unspecified disorder of skin and subcutaneous tissue
  • atracurium
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • avanafil
    • Unspecified disorder of skin and subcutaneous tissue
  • axitinib
    • Unspecified disorder of skin and subcutaneous tissue
  • azathioprine
    • Unspecified disorder of skin and subcutaneous tissue
  • azilsartan medoxomil
    • Unspecified disorder of skin and subcutaneous tissue
  • baclofen
    • Unspecified disorder of skin and subcutaneous tissue
  • bazedoxifene
    • Unspecified disorder of skin and subcutaneous tissue
  • bendamustine
    • Unspecified disorder of skin and subcutaneous tissue
  • benzoyl
    • Unspecified disorder of skin and subcutaneous tissue
  • betahistine
    • Unspecified disorder of skin and subcutaneous tissue
  • betaine
    • Unspecified disorder of skin and subcutaneous tissue
  • betamethasone valerate
    • Unspecified disorder of skin and subcutaneous tissue
  • betaxolol
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • bexarotene
    • Skin disorder: common, 18% - 26%
    • Unspecified disorder of skin and subcutaneous tissue
  • bicalutamide
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • bile salt
    • Unspecified disorder of skin and subcutaneous tissue
  • bimatoprost
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • bisoprolol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • boceprevir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • bortezomib
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • bosentan
    • Unspecified disorder of skin and subcutaneous tissue
  • bosutinib
    • Unspecified disorder of skin and subcutaneous tissue
  • brimonidine
    • Unspecified disorder of skin and subcutaneous tissue
  • brinzolamide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • bromazepam
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • bromhexine
    • Unspecified disorder of skin and subcutaneous tissue
  • bromocriptine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • budesonide
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • bupivacaine
    • Unspecified disorder of skin and subcutaneous tissue: 0% - 8.25%
  • buprenorphine
    • Unspecified disorder of skin and subcutaneous tissue
  • bupropion
    • Skin disorder: 1.9% - 2.4%
    • Unspecified disorder of skin and subcutaneous tissue: 3%
  • busulfan
    • Unspecified disorder of skin and subcutaneous tissue
  • cabazitaxel
    • Unspecified disorder of skin and subcutaneous tissue
  • cabozantinib
    • Unspecified disorder of skin and subcutaneous tissue
  • caffeine
    • Skin breakdown: 2.17%
  • canagliflozin
    • Unspecified disorder of skin and subcutaneous tissue
  • candesartan cilexetil
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • capecitabine
    • Unspecified disorder of skin and subcutaneous tissue
  • capsaicin
    • Unspecified disorder of skin and subcutaneous tissue
  • carbamazepine
    • Unspecified disorder of skin and subcutaneous tissue
  • carbimazole
    • Unspecified disorder of skin and subcutaneous tissue
  • carboplatin
    • Unspecified disorder of skin and subcutaneous tissue
  • carvedilol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ceftaroline
    • Unspecified disorder of skin and subcutaneous tissue
  • ceftazidime
    • Unspecified disorder of skin and subcutaneous tissue
  • ceftobiprole
    • Unspecified disorder of skin and subcutaneous tissue
  • cefuroxime
    • Unspecified disorder of skin and subcutaneous tissue
  • celecoxib
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • celiprolol
    • Skin disorder
  • cephalexin
    • Unspecified disorder of skin and subcutaneous tissue
  • cetirizine
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • cevimeline
    • Skin disorder
  • chloramphenicol
    • Unspecified disorder of skin and subcutaneous tissue
  • ciclopirox
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • cidofovir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
    • Skin disorder
  • cilazapril
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • cilostazol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • cinacalcet
    • Unspecified disorder of skin and subcutaneous tissue
  • ciprofloxacin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • cisplatin
    • Unspecified disorder of skin and subcutaneous tissue
  • citalopram
    • Skin disorder: uncommon
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • cladribine
    • Unspecified disorder of skin and subcutaneous tissue
  • clarithromycin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 3.18% - 3.2%
  • clobazam
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • clobetasol
    • Unspecified disorder of skin and subcutaneous tissue: 1.67% - 3.33%
  • clobetasol propionate
    • Unspecified disorder of skin and subcutaneous tissue
  • clobetasone butyrate
    • Unspecified disorder of skin and subcutaneous tissue
  • clodronate
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • clofarabine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • clomipramine
    • Unspecified disorder of skin and subcutaneous tissue
  • clonazepam
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • clonidine
    • Unspecified disorder of skin and subcutaneous tissue
  • clopidogrel
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • clozapine
    • Unspecified disorder of skin and subcutaneous tissue
  • cobicistat
    • Unspecified disorder of skin and subcutaneous tissue
  • colchicine
    • Skin disorder
  • colestimide
    • Unspecified disorder of skin and subcutaneous tissue
  • conivaptan
    • Unspecified disorder of skin and subcutaneous tissue
  • copolymer 1
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • cortisol
    • Unspecified disorder of skin and subcutaneous tissue
  • cosyntropin
    • Unspecified disorder of skin and subcutaneous tissue
  • crizotinib
    • Unspecified disorder of skin and subcutaneous tissue: 0% - 8.72%
  • cyclizine
    • Skin disorder
  • cyproterone acetate
    • Unspecified disorder of skin and subcutaneous tissue
  • cysteamine
    • Unspecified disorder of skin and subcutaneous tissue
  • cytarabine
    • Unspecified disorder of skin and subcutaneous tissue
  • d-telaprevir
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • dabigatran etexilate
    • Unspecified disorder of skin and subcutaneous tissue
  • dabrafenib
    • Unspecified disorder of skin and subcutaneous tissue
  • dalbavancin
    • Unspecified disorder of skin and subcutaneous tissue
  • dalteparin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: uncommon
  • dapagliflozin
    • Unspecified disorder of skin and subcutaneous tissue
  • darifenacin
    • Unspecified disorder of skin and subcutaneous tissue
  • darunavir
    • Unspecified disorder of skin and subcutaneous tissue
  • dasatinib
    • Unspecified disorder of skin and subcutaneous tissue
  • deferasirox
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • deferiprone
    • Unspecified disorder of skin and subcutaneous tissue
  • deferoxamine
    • Unspecified disorder of skin and subcutaneous tissue
  • degarelix
    • Unspecified disorder of skin and subcutaneous tissue
  • delamanid
    • Unspecified disorder of skin and subcutaneous tissue
  • delavirdine
    • Skin disorder
  • delta 9-THC
    • Unspecified disorder of skin and subcutaneous tissue
  • demethyl
    • Unspecified disorder of skin and subcutaneous tissue
  • deprenyl
    • Skin disorder: 6%
    • Unspecified disorder of skin and subcutaneous tissue
  • desmopressin
    • Unspecified disorder of skin and subcutaneous tissue
  • desogestrel
    • Unspecified disorder of skin and subcutaneous tissue
  • desonide
    • Unspecified disorder of skin and subcutaneous tissue: 2.58% - 3.09%
  • desvenlafaxine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • dexrazoxane
    • Unspecified disorder of skin and subcutaneous tissue
  • diazepam
    • Unspecified disorder of skin and subcutaneous tissue
  • diclofenac
    • Unspecified disorder of skin and subcutaneous tissue
  • dihydrocodeine
    • Unspecified disorder of skin and subcutaneous tissue
  • dipyridamole
    • Unspecified disorder of skin and subcutaneous tissue
  • disopyramide
    • Skin disorder
  • docetaxel
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • dolutegravir
    • Unspecified disorder of skin and subcutaneous tissue
  • doripenem
    • Unspecified disorder of skin and subcutaneous tissue
  • doxazosin
    • Skin disorder: postmarketing
  • doxepin
    • Unspecified disorder of skin and subcutaneous tissue
  • doxorubicin
    • Skin disorder: common
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • dronedarone
    • Unspecified disorder of skin and subcutaneous tissue
  • drospirenone (DRSP
    • Unspecified disorder of skin and subcutaneous tissue
  • duloxetine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 6%
  • efavirenz
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • eletriptan
    • Skin disorder: infrequent
    • Unspecified disorder of skin and subcutaneous tissue
  • elvitegravir
    • Unspecified disorder of skin and subcutaneous tissue
  • emedastine
    • Unspecified disorder of skin and subcutaneous tissue
  • emtricitabine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • entacapone
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • entecavir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • epinephrine
    • Unspecified disorder of skin and subcutaneous tissue
  • eplerenone
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • eribulin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • erlotinib
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ertapenem
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • eslicarbazepine
    • Unspecified disorder of skin and subcutaneous tissue: 1%
  • eslicarbazepine acetate
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • esmolol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • estradiol
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • ethosuximide
    • Unspecified disorder of skin and subcutaneous tissue
  • etoposide
    • Unspecified disorder of skin and subcutaneous tissue
  • etoricoxib
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • etravirine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • everolimus
    • Unspecified disorder of skin and subcutaneous tissue
  • exemestane
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • exenatide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ezetimibe
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • famciclovir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • febuxostat
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • fenofibrate
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • fentanyl
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 1% - 13%
  • fesoterodine
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • fidaxomicin
    • Unspecified disorder of skin and subcutaneous tissue
  • flavoxate
    • Other dermatoses
  • flecainide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • florbetapir
    • Unspecified disorder of skin and subcutaneous tissue
  • flucloxacillin
    • Unspecified disorder of skin and subcutaneous tissue
  • fluconazole
    • Skin disorder: postmarketing, rare
    • Unspecified disorder of skin and subcutaneous tissue
  • fludarabine
    • Skin disorder: 0% - 6%
  • fluocinonide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • fluorescein
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • fluoxetine
    • Unspecified disorder of skin and subcutaneous tissue
  • fluphenazine
    • Skin disorder
  • fluphenazine decanoate
    • Skin disorder
  • flutamide
    • Unspecified disorder of skin and subcutaneous tissue
  • fluticasone propionate
    • Unspecified disorder of skin and subcutaneous tissue
  • fluticasone/salmeterol
    • Unspecified disorder of skin and subcutaneous tissue
  • fluvastatin
    • Unspecified disorder of skin and subcutaneous tissue
  • fondaparinux
    • Unspecified disorder of skin and subcutaneous tissue
  • formoterol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • fosamprenavir
    • Unspecified disorder of skin and subcutaneous tissue: rare, common
  • fosaprepitant
    • Unspecified disorder of skin and subcutaneous tissue
  • fosaprepitant dimeglumine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • fosfomycin
    • Skin disorder
  • fosfomycin trometamol
    • Skin disorder
  • fospropofol
    • Unspecified disorder of skin and subcutaneous tissue: 16.1% - 27.6%
  • fotemustine
    • Unspecified disorder of skin and subcutaneous tissue
  • furosemide
    • Unspecified disorder of skin and subcutaneous tissue
  • fusidic acid
    • Unspecified disorder of skin and subcutaneous tissue
  • gabapentin
    • Skin disorder: infrequent
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • gadobenate dimeglumine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • gadofosveset
    • Unspecified disorder of skin and subcutaneous tissue
  • gadolinium
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • gadoversetamide
    • Unspecified disorder of skin and subcutaneous tissue
  • galantamine
    • Unspecified disorder of skin and subcutaneous tissue
  • ganciclovir
    • Unspecified disorder of skin and subcutaneous tissue
  • gefitinib
    • Unspecified disorder of skin and subcutaneous tissue: very common, 4.6%
  • gemcitabine
    • Unspecified disorder of skin and subcutaneous tissue
  • gemfibrozil
    • Unspecified disorder of skin and subcutaneous tissue
  • gemifloxacin
    • Unspecified disorder of skin and subcutaneous tissue
  • gliclazide
    • Skin disorder: 1.9% - 2%
    • Unspecified disorder of skin and subcutaneous tissue
  • glycopyrrolate
    • Unspecified disorder of skin and subcutaneous tissue
  • granisetron
    • Unspecified disorder of skin and subcutaneous tissue
  • haloperidol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • hepatitis B vaccines
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • hetastarch
    • Unspecified disorder of skin and subcutaneous tissue
  • histamine
    • Unspecified disorder of skin and subcutaneous tissue
  • hydrocodone
    • Unspecified disorder of skin and subcutaneous tissue
  • hydromorphone
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • hydroxocobalamin
    • Unspecified disorder of skin and subcutaneous tissue
  • hydroxybutyrate
    • Unspecified disorder of skin and subcutaneous tissue
  • hydroxychloroquine
    • Unspecified disorder of skin and subcutaneous tissue
  • hydroxyurea
    • Unspecified disorder of skin and subcutaneous tissue
  • ibandronate
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: 1.3% - 3%
  • ibuprofen
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • icodextrin
    • Skin disorder
  • idarubicin
    • Unspecified disorder of skin and subcutaneous tissue
  • ifosfamide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • iloprost
    • Unspecified disorder of skin and subcutaneous tissue
  • imatinib
    • Skin disorder: 0% - 4.35%
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • imipramine
    • Unspecified disorder of skin and subcutaneous tissue
  • imiquimod
    • Skin disorder
    • Skin breakdown: 0.5%
    • Unspecified disorder of skin and subcutaneous tissue
  • indacaterol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • indapamide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • indinavir
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • insulin detemir
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • iodide
    • Unspecified disorder of skin and subcutaneous tissue
  • iohexol
    • Skin disorder
  • iopromide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ipratropium bromide
    • Unspecified disorder of skin and subcutaneous tissue
  • irbesartan
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • iron sucrose
    • Unspecified disorder of skin and subcutaneous tissue
  • isosorbide-5-mononitrate
    • Skin disorder
  • isradipine
    • Unspecified disorder of skin and subcutaneous tissue
  • itraconazole
    • Skin disorder: 1% - 2%
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ivabradine
    • Unspecified disorder of skin and subcutaneous tissue
  • ivacaftor
    • Unspecified disorder of skin and subcutaneous tissue
  • ixabepilone
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • ketoconazole
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ketorolac tromethamine
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • lacosamide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • lactate
    • Skin disorder
  • lamivudine
    • Unspecified disorder of skin and subcutaneous tissue
  • lanreotide
    • Unspecified disorder of skin and subcutaneous tissue
  • lansoprazole
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • lapatinib
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • lasofoxifene
    • Unspecified disorder of skin and subcutaneous tissue
  • latanoprost
    • Unspecified disorder of skin and subcutaneous tissue
  • leflunomide
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: very rare
  • lenalidomide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • lercanidipine
    • Unspecified disorder of skin and subcutaneous tissue
  • letrozole
    • Skin disorder: 0.663% - 32.4%
    • Unspecified disorder of skin and subcutaneous tissue
  • leucovorin
    • Skin disorder
  • leuprorelin acetate
    • Unspecified disorder of skin and subcutaneous tissue: uncommon
  • levetiracetam
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • levonorgestrel
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • linaclotide
    • Unspecified disorder of skin and subcutaneous tissue
  • linagliptin
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • linezolid
    • Skin disorder: postmarketing, 0% - 2%
  • lisdexamfetamine dimesylate
    • Unspecified disorder of skin and subcutaneous tissue: 3%
  • lithium carbonate
    • Skin disorder
  • lomefloxacin
    • Skin disorder
  • lomitapide
    • Unspecified disorder of skin and subcutaneous tissue
  • loperamide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • loratadine
    • Unspecified disorder of skin and subcutaneous tissue
  • lorcaserin
    • Unspecified disorder of skin and subcutaneous tissue
  • lormetazepam
    • Unspecified disorder of skin and subcutaneous tissue
  • lubiprostone
    • Unspecified disorder of skin and subcutaneous tissue
  • lurasidone
    • Unspecified disorder of skin and subcutaneous tissue
  • mTHPC
    • Unspecified disorder of skin and subcutaneous tissue
  • mannitol
    • Unspecified disorder of skin and subcutaneous tissue
  • maprotiline
    • Unspecified disorder of skin and subcutaneous tissue
  • maraviroc
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • medroxyprogesterone
    • Skin disorder: postmarketing
  • medroxyprogesterone acetate
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • mefenamic acid
    • Unspecified disorder of skin and subcutaneous tissue
  • mefloquine
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • megestrol
    • Skin disorder
  • melatonin
    • Unspecified disorder of skin and subcutaneous tissue
  • meloxicam
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 0% - 4.5%
  • melphalan
    • Unspecified disorder of skin and subcutaneous tissue: rare
  • memantine
    • Skin disorder: postmarketing
  • meropenem
    • Unspecified disorder of skin and subcutaneous tissue: common
  • metformin
    • Unspecified disorder of skin and subcutaneous tissue
  • methotrexate
    • Unspecified disorder of skin and subcutaneous tissue
  • methyldopa
    • Unspecified disorder of skin and subcutaneous tissue
  • methylene blue
    • Unspecified disorder of skin and subcutaneous tissue
  • methylnaltrexone
    • Unspecified disorder of skin and subcutaneous tissue
  • methylphenidate
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 1.7%
  • methylprednisolone
    • Unspecified disorder of skin and subcutaneous tissue
  • metoprolol
    • Unspecified disorder of skin and subcutaneous tissue
  • metronidazole
    • Unspecified disorder of skin and subcutaneous tissue: 6.35% - 6.46%
  • metyrapone
    • Unspecified disorder of skin and subcutaneous tissue
  • mianserin
    • Unspecified disorder of skin and subcutaneous tissue
  • midazolam
    • Unspecified disorder of skin and subcutaneous tissue
  • midodrine
    • Unspecified disorder of skin and subcutaneous tissue
  • mifepristone
    • Unspecified disorder of skin and subcutaneous tissue
  • milnacipran
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue
  • minoxidil
    • Unspecified disorder of skin and subcutaneous tissue
  • mirabegron
    • Unspecified disorder of skin and subcutaneous tissue
  • mirtazapine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • mitotane
    • Unspecified disorder of skin and subcutaneous tissue
  • mitoxantrone
    • Skin disorder
  • mivacurium
    • Unspecified disorder of skin and subcutaneous tissue
  • modafinil
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • monomethylfumarate
    • Unspecified disorder of skin and subcutaneous tissue
  • montelukast
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • morphine
    • Unspecified disorder of skin and subcutaneous tissue
  • moxifloxacin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • mupirocin
    • Unspecified disorder of skin and subcutaneous tissue
  • mycophenolate mofetil
    • Skin disorder: 8.7% - 12.5%
    • Unspecified disorder of skin and subcutaneous tissue
  • mycophenolic acid
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • nalmefene
    • Unspecified disorder of skin and subcutaneous tissue
  • naloxone
    • Unspecified disorder of skin and subcutaneous tissue
  • naltrexone
    • Unspecified disorder of skin and subcutaneous tissue
  • naproxen
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • naratriptan
    • Skin disorder: rare
  • nebivolol
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue
  • nelfinavir
    • Unspecified disorder of skin and subcutaneous tissue
  • neostigmine
    • Unspecified disorder of skin and subcutaneous tissue
  • nepafenac
    • Unspecified disorder of skin and subcutaneous tissue
  • nevirapine
    • Unspecified disorder of skin and subcutaneous tissue
  • niacin
    • Unspecified disorder of skin and subcutaneous tissue
  • nicorandil
    • Unspecified disorder of skin and subcutaneous tissue: very rare
  • nifedipine
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • nilotinib
    • Unspecified disorder of skin and subcutaneous tissue: 0% - 36%
  • nitrogen mustard
    • Unspecified disorder of skin and subcutaneous tissue
  • nitroglycerin
    • Unspecified disorder of skin and subcutaneous tissue
  • norethisterone
    • Unspecified disorder of skin and subcutaneous tissue
  • ofatumumab
    • Unspecified disorder of skin and subcutaneous tissue
  • ofloxacin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • olanzapine
    • Unspecified disorder of skin and subcutaneous tissue
  • olmesartan
    • Unspecified disorder of skin and subcutaneous tissue
  • olodaterol
    • Unspecified disorder of skin and subcutaneous tissue
  • olopatadine
    • Unspecified disorder of skin and subcutaneous tissue
  • olsalazine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • omeprazole
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ondansetron
    • Unspecified disorder of skin and subcutaneous tissue
  • orlistat
    • Unspecified disorder of skin and subcutaneous tissue
  • orphenadrine
    • Other dermatoses
  • oseltamivir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ospemifene
    • Unspecified disorder of skin and subcutaneous tissue: 1.6%
  • oxaliplatin
    • Skin disorder: 0.6% - 36%
    • Unspecified disorder of skin and subcutaneous tissue
  • oxcarbazepine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • oxybutynin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • oxycodone
    • Unspecified disorder of skin and subcutaneous tissue
  • oxymorphone
    • Unspecified disorder of skin and subcutaneous tissue
  • oxytocin injection
    • Unspecified disorder of skin and subcutaneous tissue
  • paclitaxel
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 0% - 5.22%
  • paliperidone
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • palonosetron
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • pantoprazole
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • parecoxib
    • Unspecified disorder of skin and subcutaneous tissue
  • paricalcitol
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • paroxetine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • pazopanib
    • Skin disorder: 0% - 11%
    • Unspecified disorder of skin and subcutaneous tissue
  • pegaptanib
    • Unspecified disorder of skin and subcutaneous tissue
  • pemetrexed
    • Unspecified disorder of skin and subcutaneous tissue
  • penciclovir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • pentostatin
    • Skin disorder: 4% - 17%
  • pentoxifylline
    • Unspecified disorder of skin and subcutaneous tissue
  • perindopril
    • Unspecified disorder of skin and subcutaneous tissue
  • phenylephrine
    • Unspecified disorder of skin and subcutaneous tissue
  • phenyllactate
    • Skin disorder
  • pimecrolimus
    • Unspecified disorder of skin and subcutaneous tissue
  • pimozide
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • pioglitazone
    • Unspecified disorder of skin and subcutaneous tissue
  • piperacillin
    • Unspecified disorder of skin and subcutaneous tissue
  • pirfenidone
    • Unspecified disorder of skin and subcutaneous tissue
  • pixantrone
    • Unspecified disorder of skin and subcutaneous tissue
  • podophyllotoxin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • pomalidomide
    • Unspecified disorder of skin and subcutaneous tissue
  • ponatinib
    • Unspecified disorder of skin and subcutaneous tissue
  • posaconazole
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: 1.72% - 4.17%
  • pramipexole
    • Skin disorder: 2%
    • Unspecified disorder of skin and subcutaneous tissue
  • prasugrel
    • Unspecified disorder of skin and subcutaneous tissue
  • praziquantel
    • Unspecified disorder of skin and subcutaneous tissue
  • prednisone
    • Unspecified disorder of skin and subcutaneous tissue
  • pregabalin
    • Skin disorder: infrequent
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • primidone
    • Unspecified disorder of skin and subcutaneous tissue
  • prochlorperazine
    • Skin disorder
  • progesterone
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • proguanil
    • Unspecified disorder of skin and subcutaneous tissue
  • propafenone
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • propranolol
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • prostacyclin
    • Unspecified disorder of skin and subcutaneous tissue
  • prucalopride
    • Unspecified disorder of skin and subcutaneous tissue
  • quetiapine
    • Unspecified disorder of skin and subcutaneous tissue
  • quinapril
    • Unspecified disorder of skin and subcutaneous tissue
  • quinidine
    • Unspecified disorder of skin and subcutaneous tissue
  • raloxifene
    • Unspecified disorder of skin and subcutaneous tissue
  • raltegravir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • ramipril
    • Unspecified disorder of skin and subcutaneous tissue
  • ranolazine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • rapamycin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: rare
  • rasagiline
    • Unspecified disorder of skin and subcutaneous tissue
  • reboxetine
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: 14.3%
  • regadenoson
    • Unspecified disorder of skin and subcutaneous tissue
  • regorafenib
    • Unspecified disorder of skin and subcutaneous tissue
  • remifentanil
    • Unspecified disorder of skin and subcutaneous tissue
  • repaglinide
    • Unspecified disorder of skin and subcutaneous tissue
  • retapamulin
    • Unspecified disorder of skin and subcutaneous tissue
  • retinoic acid
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
    • Skin disorder: very common, 0% - 8%
  • ribavirin
    • Skin disorder: common, 47%
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • rifabutin
    • Unspecified disorder of skin and subcutaneous tissue
  • rifampicin
    • Unspecified disorder of skin and subcutaneous tissue
  • rifapentine
    • Skin disorder
  • rifaximin
    • Unspecified disorder of skin and subcutaneous tissue
  • rilpivirine
    • Unspecified disorder of skin and subcutaneous tissue
  • riluzole
    • Skin disorder: infrequent, uncommon
    • Unspecified disorder of skin and subcutaneous tissue
  • rimonabant
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • risedronate
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • risperidone
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 0% - 52%
  • ritonavir
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • rivaroxaban
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • rivastigmine
    • Skin disorder: frequent
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • roflumilast
    • Unspecified disorder of skin and subcutaneous tissue
  • ropinirole
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: 3%
  • ropivacaine
    • Skin disorder
  • rotigotine
    • Unspecified disorder of skin and subcutaneous tissue
  • rufinamide
    • Unspecified disorder of skin and subcutaneous tissue
  • ruxolitinib
    • Unspecified disorder of skin and subcutaneous tissue
  • salbutamol
    • Skin disorder: postmarketing
  • salmon calcitonin acetate
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • saquinavir
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • scopolamine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • sertraline
    • Skin disorder: postmarketing, rare
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • sevelamer hydrochloride
    • Skin disorder
  • sevoflurane
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • sibutramine
    • Skin disorder
  • sildenafil
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • silodosin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • sitagliptin
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • sitaxsentan
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • sofosbuvir
    • Unspecified disorder of skin and subcutaneous tissue
  • solifenacin
    • Unspecified disorder of skin and subcutaneous tissue
  • sorafenib
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • stavudine
    • Unspecified disorder of skin and subcutaneous tissue: very rare
  • stiripentol
    • Unspecified disorder of skin and subcutaneous tissue
  • strontium ranelate
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • sulfasalazine
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • sumatriptan
    • Skin breakdown
  • sunitinib
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • tacrolimus
    • Skin disorder: 1% - 4%
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
  • tadalafil
    • Unspecified disorder of skin and subcutaneous tissue
  • tamsulosin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • tapentadol
    • Unspecified disorder of skin and subcutaneous tissue
  • teduglutide
    • Unspecified disorder of skin and subcutaneous tissue
  • tegaserod
    • Unspecified disorder of skin and subcutaneous tissue
  • telavancin
    • Unspecified disorder of skin and subcutaneous tissue
  • telithromycin
    • Unspecified disorder of skin and subcutaneous tissue
  • telmisartan
    • Skin disorder: common
    • Unspecified disorder of skin and subcutaneous tissue: rare
  • temozolomide
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue
  • temsirolimus
    • Unspecified disorder of skin and subcutaneous tissue
  • tenofovir
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • tenofovir disoproxil fumarate
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, 5%
  • tenoxicam
    • Unspecified disorder of skin and subcutaneous tissue
  • terbinafine
    • Skin disorder: 1.9%
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • tesamorelin
    • Unspecified disorder of skin and subcutaneous tissue
  • testosterone
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • testosterone enanthate
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • testosterone propionate
    • Unspecified disorder of skin and subcutaneous tissue
  • testosterone undecanoate
    • Unspecified disorder of skin and subcutaneous tissue
  • tetrabenazine
    • Unspecified disorder of skin and subcutaneous tissue
  • tetraen
    • Unspecified disorder of skin and subcutaneous tissue
  • tetrahydrobiopterin
    • Unspecified disorder of skin and subcutaneous tissue: 5.41%
  • thalidomide
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • thiotepa
    • Unspecified disorder of skin and subcutaneous tissue
  • thymidine
    • Unspecified disorder of skin and subcutaneous tissue
  • tibolone
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • ticagrelor
    • Unspecified disorder of skin and subcutaneous tissue
  • tigecycline
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • timolol
    • Unspecified disorder of skin and subcutaneous tissue
  • tinidazole
    • Unspecified disorder of skin and subcutaneous tissue
  • tiotropium
    • Unspecified disorder of skin and subcutaneous tissue
  • tipranavir
    • Unspecified disorder of skin and subcutaneous tissue
  • tizanidine
    • Unspecified disorder of skin and subcutaneous tissue
  • tobramycin
    • Unspecified disorder of skin and subcutaneous tissue
  • tofacitinib
    • Unspecified disorder of skin and subcutaneous tissue
  • tolcapone
    • Skin disorder: infrequent
    • Unspecified disorder of skin and subcutaneous tissue: common
  • tolvaptan
    • Unspecified disorder of skin and subcutaneous tissue
  • topiramate
    • Skin disorder: 1% - 3.1%
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • topotecan
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • toremifene
    • Unspecified disorder of skin and subcutaneous tissue
  • trabectedin
    • Unspecified disorder of skin and subcutaneous tissue
  • tramadol
    • Skin disorder: postmarketing, uncommon
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • tramazoline
    • Unspecified disorder of skin and subcutaneous tissue
  • trametinib
    • Unspecified disorder of skin and subcutaneous tissue
  • trandolapril
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • travoprost
    • Unspecified disorder of skin and subcutaneous tissue: uncommon
  • trifluoperazine
    • Skin disorder
  • trimethoprim
    • Unspecified disorder of skin and subcutaneous tissue
  • trimethoprim-sulfamethoxazole
    • Unspecified disorder of skin and subcutaneous tissue
  • tropisetron
    • Unspecified disorder of skin and subcutaneous tissue
  • trospium chloride
    • Unspecified disorder of skin and subcutaneous tissue
  • trovafloxacin
    • Skin disorder
  • ulipristal
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • umeclidinium
    • Unspecified disorder of skin and subcutaneous tissue
  • ustekinumab
    • Unspecified disorder of skin and subcutaneous tissue
  • v 1784
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue
  • valganciclovir
    • Unspecified disorder of skin and subcutaneous tissue
  • valproate
    • Unspecified disorder of skin and subcutaneous tissue
  • valsartan
    • Unspecified disorder of skin and subcutaneous tissue
  • vandetanib
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • vardenafil
    • Unspecified disorder of skin and subcutaneous tissue
  • varenicline
    • Unspecified disorder of skin and subcutaneous tissue
  • vecuronium
    • Unspecified disorder of skin and subcutaneous tissue
  • vemurafenib
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
  • vernakalant
    • Unspecified disorder of skin and subcutaneous tissue
  • verteporfin
    • Unspecified disorder of skin and subcutaneous tissue
  • vigabatrin
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
  • vilazodone
    • Unspecified disorder of skin and subcutaneous tissue
  • vildagliptin
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • vinflunine
    • Unspecified disorder of skin and subcutaneous tissue
  • vinorelbine
    • Skin disorder: postmarketing
    • Unspecified disorder of skin and subcutaneous tissue
  • vismodegib
    • Unspecified disorder of skin and subcutaneous tissue
  • voriconazole
    • Skin disorder
    • Unspecified disorder of skin and subcutaneous tissue
  • warfarin
    • Skin disorder
  • x M22
    • Unspecified disorder of skin and subcutaneous tissue
  • zalcitabine
    • Skin disorder
  • zaleplon
    • Unspecified disorder of skin and subcutaneous tissue: uncommon
  • zanamivir
    • Unspecified disorder of skin and subcutaneous tissue
  • ziconotide
    • Unspecified disorder of skin and subcutaneous tissue
  • zidovudine
    • Unspecified disorder of skin and subcutaneous tissue
  • ziprasidone
    • Unspecified disorder of skin and subcutaneous tissue: postmarketing
  • zoledronic acid
    • Unspecified disorder of skin and subcutaneous tissue
  • zolmitriptan
    • Skin disorder: infrequent
  • zolpidem
    • Unspecified disorder of skin and subcutaneous tissue
  • zonisamide
    • Unspecified disorder of skin and subcutaneous tissue
  • zuclopenthixol
    • Unspecified disorder of skin and subcutaneous tissue

Drugs with this indication